Plus   Neg

Hochschild Mining FY Profit Rises - Quick Facts

Hochschild Mining Plc. (HOC.L) reported that its profit attributable to equity shareholders of the parent from continuing operations for the year ended 31 December 2019 rose to $28.95 million or $0.06 per share from $12.84 million or $0.03 per share in the prior year.

Profit before income tax--pre-exceptional-- was up 89% at $103.4 million.

Gross revenue from continuing operations increased by 6% to $780.4 million from last year's $733.6 million due to an increase in the average precious metals prices received as well as a rise in gold sales offsetting a fall in ounces sold of silver in line with decreased silver production.

Annual net revenue grew to $755.7 million from $704.3 million last year.

The company expects attributable production in 2020 of 422,000 gold equivalent ounces or 36 million silver equivalent ounces.

The company said its board recommended a final dividend of 2.335 cents per share.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration granted approval for Coagulation Factor VIIa (Recombinant) to biopharmaceutical company LFB S.A. for the treatment and control of bleeding episodes occurring in adults and adolescents - 12 years of age and older- with hemophilia A or B with inhibitors. It is marketed as Sevenfact by LFB. Chipotle Mexican Grill, Inc. is giving away 100,000 burritos to healthcare workers, who are at present fighting in the front line against coronavirus or Covid-19 pandemic. The food chain has asked healthcare teams to submit their application by Thursday, April 2, which is this year's National Burrito day. The offer is valid for a free preconfigured Burritos by the Box order of 25 burritos. The U.S. Food and Drug Administration has urged to withdraw Sanofi's heartburn drug Ranitidine as well as its generics from the market with immediate effect for possible contamination. The recall involves all prescription and over-the-counter or OTC ranitidine drugs, commonly known by the brand name Zantac. The recall includes generic products that contain ranitidine made by Novartis, Endo...
Follow RTT